Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 198

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Selection criteria for genetic assessment of patients with familial melanoma

Open access
Leachman, Sancy A., Carucci, John, Kohlmann, Wendy, Banks, Kimberly C., Asgari, Maryam M., Bergman, Wilma, Bianchi-Scarrà, Giovanna, Brentnall, Teresa, Bressac-de Paillerets, Brigitte, Bruno, William, Curiel-Lewandrowski, Clara, de Snoo, Femke A., Debniak, Tadeusz, Demierre, Marie-France, Elder, David, Goldstein, Alisa M., Grant-Kels, Jane, Halpern, Allan C., Ingvar, Christian, Kefford, Richard F., Lang, Julie, MacKie, Rona M., Mann, Graham J., Mueller, Kurt, Newton-Bishop, Julia, Olsson, Håkan, Petersen, Gloria M., Puig, Susana, Rigel, Darrell, Swetter, Susan M., Tucker, Margaret A., Yakobson, Emanuel, Zitelli, John A., Tsao, Hensin · 2009 · Journal of the American Academy of Dermatology

Abstract

Approximately 5% to 10% of melanoma may be hereditary in nature, and about 2% of melanoma can be specifically attributed to pathogenic germline mutations in cyclin-dependent kinase inhibitor 2A (CDKN2A). To appropriately identify the small proportion of patients who benefit most from referral to a genetics specialist for consideration of genetic testing for CDKN2A, we have reviewed available published studies of CDKN2A mutation analysis in cohorts with invasive, cutaneous melanoma and found variability in the rate of CDKN2A mutations based on geography, ethnicity, and the type of study and eligibility criteria used. Except in regions of high melanoma incidence, such as Australia, we found higher rates of CDKN2A positivity in individuals with 3 or more primary invasive melanomas and/or families with at least one invasive melanoma and two or more other diagnoses of invasive melanoma and/or pancreatic cancer among first- or second-degree relatives on the same side of the family. The work summarized in this review should help identify individuals who are appropriate candidates for referral for genetic consultation and possible testing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2009.03.016

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 198

Metadata

Authors
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., Curiel-Lewandrowski, C., de Snoo, F. A., Debniak, T., Demierre, M.-F., Elder, D., Goldstein, A. M., Grant-Kels, J., Halpern, A. C., Ingvar, C., Kefford, R. F., Lang, J., MacKie, R. M., Mann, G. J., Mueller, K., Newton-Bishop, J., Olsson, H., Petersen, G. M., Puig, S., Rigel, D., Swetter, S. M., Tucker, M. A., Yakobson, E., Zitelli, J. A., & Tsao, H.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2009-10
Volume
61
Issue
4
Pages
677.e1-677.e14
ISSN
0190-9622 (ISSN-L)
OpenAlex
W2106621675
Cited by
198
References
2
FWCI
5.67
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Selection criteria for genetic assessment of patients with familial melanoma. https://app.cochat.ai/papers/10.1016/j.jaad.2009.03.016
The paper
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., Curiel-Lewandrowski, C., de Snoo, F. A., Debniak, T., Demierre, M.-F., Elder, D., Goldstein, A. M., Grant-Kels, J., Halpern, A. C., Ingvar, C., . . . Tsao, H. (2009). Selection criteria for genetic assessment of patients with familial melanoma. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2009.03.016

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.